Chongqing Pharscin Pharmaceutical Co., Ltd.

Shenzhen Stock Exchange 002907.SZ

Chongqing Pharscin Pharmaceutical Co., Ltd. Market Capitalization on January 27, 2025: USD 707.06 M

Chongqing Pharscin Pharmaceutical Co., Ltd. Market Capitalization is USD 707.06 M on January 27, 2025, a -14.44% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.
  • Chongqing Pharscin Pharmaceutical Co., Ltd. 52-week high Market Capitalization is USD 904.73 M on May 14, 2024, which is 27.96% above the current Market Capitalization.
  • Chongqing Pharscin Pharmaceutical Co., Ltd. 52-week low Market Capitalization is USD 610.87 M on February 05, 2024, which is -13.60% below the current Market Capitalization.
  • Chongqing Pharscin Pharmaceutical Co., Ltd. average Market Capitalization for the last 52 weeks is USD 768.91 M.
Key data
Date Market Capitalization Share Price Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S)
Market news
SV Wall Street
Shenzhen Stock Exchange: 002907.SZ

Chongqing Pharscin Pharmaceutical Co., Ltd.

CEO Ms. Xiaoying Liu
IPO Date Oct. 20, 2017
Location China
Headquarters No. 89, Middle Sec of Huangshan Ave
Employees 1,411
Sector Healthcare
Industries
Pharmaceuticals Biotechnology Cosmetics Drugstores & Retail Pharmacies
Description

Chongqing Pharscin Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of drugs in China. The company offers tablets, powders, granules, hard capsules, soft capsules, powder injections, freeze-dried powder injections, small volume injections, and API synthesis. It provides its products in the areas of CNS, digestion, otolaryngology, oncology, cardiovascular, and cerebrovascular related diseases. Chongqing Pharscin Pharmaceutical Co., Ltd. was founded in 1996 and is headquartered in Chongqing, China.

StockViz Staff

February 3, 2025

Any question? Send us an email